Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:APENNASDAQ:CSIINASDAQ:OFIXNASDAQ:SIBN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPENApollo Endosurgery$9.94$3.49▼$10.30$579.72M2.311.43 million shs1.66 million shsCSIICardiovascular Systems$20.00$19.98$12.26▼$20.57$843.96M0.74765,906 shs4,300 shsOFIXOrthofix Medical$10.34-0.1%$12.08$10.25▼$20.73$405.12M0.8281,301 shs814,462 shsSIBNSiBone$16.39-1.7%$16.94$11.70▼$20.05$698.54M0.93388,707 shs406,230 shs12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPENApollo Endosurgery0.00%0.00%0.00%0.00%0.00%CSIICardiovascular Systems0.00%0.00%0.00%0.00%0.00%OFIXOrthofix Medical0.00%-6.00%-6.85%-38.23%-18.45%SIBNSiBone0.00%-5.91%-10.83%+10.59%+34.68%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAPENApollo EndosurgeryN/AN/AN/AN/AN/AN/AN/AN/ACSIICardiovascular SystemsN/AN/AN/AN/AN/AN/AN/AN/AOFIXOrthofix Medical2.8375 of 5 stars3.42.00.00.01.53.31.3SIBNSiBone3.5359 of 5 stars3.52.00.03.30.02.50.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAPENApollo Endosurgery 0.00N/AN/AN/ACSIICardiovascular Systems 0.00N/AN/AN/AOFIXOrthofix Medical 2.75Moderate Buy$23.33125.66% UpsideSIBNSiBone 3.00Buy$22.5037.28% UpsideCurrent Analyst Ratings BreakdownLatest SIBN, OFIX, APEN, and CSII Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/6/2025OFIXOrthofix MedicalJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Perform ➝ Market Perform5/6/2025SIBNSiBoneTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$20.00 ➝ $22.005/6/2025SIBNSiBoneCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$25.00 ➝ $25.005/6/2025SIBNSiBoneNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$24.00 ➝ $24.00(Data available from 6/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAPENApollo Endosurgery$76.86M0.00N/AN/A$0.69 per share0.00CSIICardiovascular Systems$239.84M3.52N/AN/A$6.12 per share3.27OFIXOrthofix Medical$799.49M0.51N/AN/A$13.07 per share0.79SIBNSiBone$167.18M4.18N/AN/A$3.98 per share4.12Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAPENApollo Endosurgery-$39.84M-$1.02N/AN/AN/A-51.84%-89.48%-33.76%N/ACSIICardiovascular Systems-$36.93M-$0.97N/AN/AN/A-15.79%-15.39%-11.93%N/AOFIXOrthofix Medical-$126M-$3.69N/AN/AN/A-17.78%-28.15%-16.51%8/5/2025 (Estimated)SIBNSiBone-$30.91M-$0.64N/AN/AN/A-15.03%-16.00%-11.69%8/4/2025 (Estimated)Latest SIBN, OFIX, APEN, and CSII EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/5/2025Q1 2025SIBNSiBone-$0.24-$0.15+$0.09-$0.15$45.13 million$47.29 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAPENApollo EndosurgeryN/AN/AN/AN/AN/ACSIICardiovascular SystemsN/AN/AN/AN/AN/AOFIXOrthofix MedicalN/AN/AN/AN/AN/ASIBNSiBoneN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAPENApollo Endosurgery1.042.351.89CSIICardiovascular Systems0.086.044.92OFIXOrthofix Medical0.382.711.50SIBNSiBone0.218.537.26Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAPENApollo Endosurgery76.01%CSIICardiovascular Systems86.61%OFIXOrthofix Medical89.76%SIBNSiBone98.11%Insider OwnershipCompanyInsider OwnershipAPENApollo Endosurgery17.30%CSIICardiovascular Systems3.80%OFIXOrthofix Medical1.30%SIBNSiBone3.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAPENApollo Endosurgery20257.97 million47.94 millionNot OptionableCSIICardiovascular Systems78042.20 million40.59 millionOptionableOFIXOrthofix Medical1,61639.18 million38.67 millionOptionableSIBNSiBone35042.62 million40.95 millionOptionableSIBN, OFIX, APEN, and CSII HeadlinesRecent News About These CompaniesSI-BONE (NASDAQ:SIBN) Sees Unusually-High Trading Volume - Here's WhyJune 13, 2025 | marketbeat.comBrokers Issue Forecasts for SI-BONE FY2026 EarningsJune 13, 2025 | americanbankingnews.comCantor Fitzgerald Weighs in on SI-BONE FY2026 EarningsJune 11, 2025 | marketbeat.comHarbor Capital Advisors Inc. Sells 308,333 Shares of SI-BONE, Inc. (NASDAQ:SIBN)June 10, 2025 | marketbeat.comCharter Oak Capital Management LLC Makes New $337,000 Investment in SI-BONE, Inc. (NASDAQ:SIBN)June 8, 2025 | marketbeat.comInsider Selling: SI-BONE, Inc. (NASDAQ:SIBN) Director Sells 3,377 Shares of StockJune 6, 2025 | marketbeat.comTwo Sigma Investments LP Sells 66,105 Shares of SI-BONE, Inc. (NASDAQ:SIBN)June 6, 2025 | marketbeat.comSquarepoint Ops LLC Buys Shares of 32,060 SI-BONE, Inc. (NASDAQ:SIBN)June 5, 2025 | marketbeat.comSI-BONE to Truist Securities MedTech Conference on June 17, 2025June 4, 2025 | globenewswire.comWellington Management Group LLP Sells 523,551 Shares of SI-BONE, Inc. (NASDAQ:SIBN)June 4, 2025 | marketbeat.comSI-BONE, Inc. (NASDAQ:SIBN) Stock Position Increased by Bank of America Corp DEJune 4, 2025 | marketbeat.comSI-BONE, Inc. (NASDAQ:SIBN) Shares Sold by Two Sigma Advisers LPJune 1, 2025 | marketbeat.com15,454 Shares in SI-BONE, Inc. (NASDAQ:SIBN) Bought by Man Group plcMay 29, 2025 | marketbeat.comSI-BONE to Present at Goldman Sachs 46th Global Healthcare Conference on June 10, 2025May 28, 2025 | globenewswire.comSI-BONE’s SWOT analysis: stock poised for growth amid market expansionMay 28, 2025 | investing.comWall Street Analysts See a 34.22% Upside in Si-Bone (SIBN): Can the Stock Really Move This High?May 26, 2025 | zacks.comNuveen Asset Management LLC Has $17.72 Million Stake in SI-BONE, Inc. (NASDAQ:SIBN)May 26, 2025 | marketbeat.comSI-BONE, Inc. (NASDAQ:SIBN) Shares Bought by Lazard Asset Management LLCMay 23, 2025 | marketbeat.comNorthern Trust Corp Increases Holdings in SI-BONE, Inc. (NASDAQ:SIBN)May 23, 2025 | marketbeat.comInsider Selling: SI-BONE, Inc. (NASDAQ:SIBN) CFO Sells 2,424 Shares of StockMay 21, 2025 | insidertrades.comInsider Selling: SI-BONE, Inc. (NASDAQ:SIBN) CFO Sells 4,937 Shares of StockMay 16, 2025 | insidertrades.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeSIBN, OFIX, APEN, and CSII Company DescriptionsApollo Endosurgery NASDAQ:APENApollo Endosurgery, Inc. is a medical technology company, which focuses on the design, development, and commercialization of medical devices to advance gastrointestinal therapeutic endoscopy. It offers Endoscopy, Surgical and Other products. The firm's endoscopy product portfolio consists of the OverStitch Endoscopic Suturing System, the OverStitch Sx Endoscopic Suturing System, and the Orbera Intragastric Balloon System. Its products are used by gastroenterologists and bariatric surgeons in a variety of settings to treat multiple gastrointestinal conditions including closure of acute perforations and chronic fistulas, inadvertent perforation of the GI tract, tissue closure after the removal of abnormal lesions in the esophagus, stomach or colon, the treatment of swallowing disorders, esophageal stent fixation, and obesity. The company was founded by Christopher J. Gostout and Dennis L. McWilliams in 2005 and is headquartered in Austin, TX.Cardiovascular Systems NASDAQ:CSIICardiovascular Systems, Inc. is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. It offers orbital atherectomy systems for both peripheral and coronary commercial applications. The company was founded in 1989 and is headquartered in St. Paul, MN.Orthofix Medical NASDAQ:OFIX$10.34 -0.01 (-0.10%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$10.34 0.00 (-0.05%) As of 06/20/2025 04:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.SiBone NASDAQ:SIBN$16.39 -0.29 (-1.74%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$16.39 0.00 (-0.03%) As of 06/20/2025 05:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas New All-Time Highs Coming for Broadcom? Wall Street Says Yes Smith & Wesson Stock Falls on Earnings Miss, Tariff Woes Marvell's New AI Chip Deals Capture Wall Street’s Attention Super Micro Computer Stock's Rally Backed by Strong Financials Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer GE Aerospace Turns Engines Into Long-Term Profits 3 Reasons AMD Could Be the Hottest Stock of the Summer Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
